BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) ...Middle East

SHANGHAI, March 27, 2023 /PRNewswire/ -- BJ Bioscience, Inc. BJ Bioscience, a biotech company focusing on discovery and development of novel biologics for cancer immunotherapy, today announced that it entered into a clinical trial collaboration and supply agreement with MSD (Merck & Co.,...

Hence then, the article about bj bioscience announces clinical collaboration with msd to evaluate bj 001 in combination with keytruda pembrolizumab was published today ( Tuesday 28/03/2023 - 04:40 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab) )

Also on site :

• Kanye “Ye” West Reportedly Struggles to Stay Awake While Testifying at Los Angeles Mansion Trial
• Billboard Staff Reacts To & Ranks Harry Styles’ New Album ‘Kiss All the Time. Disco, Occasionally’ .. Billboard News
• Ted Season 2 Chaos: Seth MacFarlane & Cast Talk AI Bill Clinton, Dropping Trou, And Making Out With A Teddy Bear